Healthcare News
Bariatric surgery cuts pancreatic cancer risk for adults with or without type 2 diabetes
Adults with obesity who underwent bariatric surgery had lower risk for pancreatic cancer than those who did not have surgery.
Study finds weight loss drug semaglutide reduced COVID-19 related deaths during the pandemic
Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an international study led by researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, finds.
Analysis finds weight-loss surgery may help people with obesity manage high blood pressure
People with obesity who underwent weight-loss surgery were more likely to control their high blood pressure over a 1-to-5 year follow-period compared to those who managed their high blood pressure with medications and lifestyle management.
Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds
Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD), held in Madrid, Spain (9–13 September).
Metabolic and bariatric surgery found to prevent pre-diabetes from developing into type 2 diabetes in most patients
Patients with pre-diabetes and severe obesity who had metabolic and bariatric surgery were 20 times less likely to develop full-blown type 2 diabetes over the course of 15 years than patients with the condition who did not have surgery.
